Abstract
Churg-Strauss syndrome (CSS) is a disseminated small vessel vasculitis characterized by late-onset asthma, upper airways disease, eosinophilia and late neurological manifestations such as peripheral neuropathy. Recently, several cases of CSS have been reported in patients treated with leukotriene antagonists after weaning corticosteroids. We describe a case of CSS developed while the patient was receiving montelukast for asthma treatment, after corticosteroids withdrawal. A causal relationship between montelukast therapy and CSS is hypothesized.
| Original language | English |
|---|---|
| Pages (from-to) | 21-22 |
| Number of pages | 2 |
| Journal | Neurological Sciences |
| Volume | 25 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Apr 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Churg-Strauss syndrome
- Montelukast
- Polyneuropathy
- Vasculitis
Fingerprint
Dive into the research topics of 'Churg-Strauss syndrome associated with the leukotriene antagonist montelukast'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver